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Introduction 50
AEDs were tested at a range of concentrations that were as close as possible to 75 clinically relevant serum concentration (i.e. phenytoin , Gallagher and Sheehy, 76 
Western blotting 82
Human foetal hFOB1.19 osteoprogenitor cells (hFOBs) were cultured as described 83 previously (Humphrey et al., 2013) . After establishing that parallel differentiated cultures 84
were producing and mineralising a matrix in culture (Supplementary Figure 1) , the hFOBs 85 were treated with vehicle control (i.e. DMSO) or AEDs. Triplicate cultures of control and 86 AED-treated hFOBs were harvested by trypsination after 24 hours of treatment and analysed 87 by western blotting using an antibody against osteonectin (Santa Cruz Biotechnology), as 88 described previously (Fuller et al., 2010) . 89 90
Immunofluorescence 91
hFOBs were grown on coverslips, as described previously (Humphrey et al., 2013) . Iowa City, IA 52242), as described previously (Fuller et al., 2010) . Sequential scans were 96 performed with a Leica TCS SP5 confocal microscope with a 40× objective. To reduce 97 operator bias a fixed laser intensity was used for all image acquisition and images were only 98 acquired from fields with even DAPI staining. To reduce edge effects only the inner twowith a 20 g/mL dose (p=0.037) (Figure 1a and 1b). This statistically significant decrease is 125 identical to the decrease observed after a 24 hour treatment of hFOBs with a clinically-126 relevant concentration of valproate (Humphrey et al., 2013) . Collagen I gene expression 127 levels were unaffected, suggesting that phenytoin alters pro-collagen I protein production or 128 turnover ( Figure 1c ). We were unable to detect a statistically significant decrease in collagen 129 Total protein staining with Ponceau S was used as a loading control. After visualization using 295 a chemiluminescent system, the integrated density of the bands for osteonectin and ponceau S 296 were measured using ImageJ software (A). A dose-dependent change in the electrophoretic
